Literature DB >> 3336367

DNase I- and micrococcal nuclease-hypersensitive sites in the human apolipoprotein B gene are tissue specific.

B Levy-Wilson1, C Fortier, B D Blackhart, B J McCarthy.   

Abstract

We have mapped the DNase I- and micrococcal nuclease-hypersensitive sites present in the 5' end of the human apolipoprotein B (apo-B) gene in nuclei from cells expressing or not expressing the gene. Four DNase I-hypersensitive sites were found in nuclei from liver-derived HepG2 cells and intestine-derived CaCo-2 cells, which express the apo-B gene, but not in HeLa cells, which do not. These sites are located near positions -120, -440, -700, and +760 base pairs relative to the transcriptional start site. Undifferentiated CaCo-2 cells exhibited another site, near position -540. Six micrococcal nuclease-hypersensitive sites were found in nuclei from HepG2 and CaCo-2 cells, but not in HeLa cells or free DNA. These sites are located near positions -120, -390, -530, -700, -850, and +210. HepG2 cells exhibited another site, near position +460. Comparison of the DNA sequence of the 5' flanking regions of the human and mouse apo-B genes revealed a high degree of evolutionary conservation of short stretches of sequences in the immediate vicinity of each of the DNase I- and most of the micrococcal nuclease-hypersensitive sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336367      PMCID: PMC363081          DOI: 10.1128/mcb.8.1.71-80.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  Sites in simian virus 40 chromatin which are preferentially cleaved by endonucleases.

Authors:  W A Scott; D J Wigmore
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

2.  In vivo mapping of DNA topoisomerase II-specific cleavage sites on SV40 chromatin.

Authors:  L Yang; T C Rowe; E M Nelson; L F Liu
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

Review 3.  Active T-cell receptor genes have intron deoxyribonuclease hypersensitive sites.

Authors:  E Bier; Y Hashimoto; M I Greene; A M Maxam
Journal:  Science       Date:  1985-08-09       Impact factor: 47.728

4.  A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene.

Authors:  S D Gillies; S L Morrison; V T Oi; S Tonegawa
Journal:  Cell       Date:  1983-07       Impact factor: 41.582

5.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

Authors:  B J Bonven; E Gocke; O Westergaard
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

Review 6.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

7.  Micrococcal nuclease as a probe of DNA sequence organization and chromatin structure.

Authors:  M A Keene; S C Elgin
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

8.  Human apolipoprotein B: structure of carboxyl-terminal domains, sites of gene expression, and chromosomal localization.

Authors:  T J Knott; S C Rall; T L Innerarity; S F Jacobson; M S Urdea; B Levy-Wilson; L M Powell; R J Pease; R Eddy; H Nakai
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

9.  Nuclease-hypersensitive sites in the chromatin domain of the chicken lysozyme gene.

Authors:  H P Fritton; A E Sippel; T Igo-Kemenes
Journal:  Nucleic Acids Res       Date:  1983-06-11       Impact factor: 16.971

10.  A close association between sites of DNase I hypersensitivity and sites of enhanced cleavage by micrococcal nuclease in the 5'-flanking region of the actively transcribed ovalbumin gene.

Authors:  J S Kaye; M Bellard; G Dretzen; F Bellard; P Chambon
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

View more
  9 in total

1.  A human metallothionein pseudogene containing AG/CT repetitive elements.

Authors:  J M Walker; L Gedamu
Journal:  J Mol Evol       Date:  1990-09       Impact factor: 2.395

2.  Activation of vitellogenin II gene expression by steroid hormones in the old Japanese quail.

Authors:  S Gupta; R Upadhyay; M S Kanungo
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

3.  Nuclear translocation of p19INK4d in response to oxidative DNA damage promotes chromatin relaxation.

Authors:  Silvina V Sonzogni; María F Ogara; Daniela S Castillo; Pablo F Sirkin; J Pablo Radicella; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2014-09-10       Impact factor: 3.396

4.  Presence of regulatory sequences within intron 2 of the mouse thymidine kinase gene.

Authors:  H Rotheneder; M Grabner; E Wintersberger
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

5.  The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3.

Authors:  B Paulweber; F Sandhofer; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Prothymosin alpha is a chromatin-remodelling protein in mammalian cells.

Authors:  J Gomez-Marquez; P Rodríguez
Journal:  Biochem J       Date:  1998-07-01       Impact factor: 3.857

7.  Sequences containing the second-intron enhancer are essential for transcription of the human apolipoprotein B gene in the livers of transgenic mice.

Authors:  A R Brooks; B P Nagy; S Taylor; W S Simonet; J M Taylor; B Levy-Wilson
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

8.  Hormonal regulation of phosphoenolpyruvate carboxykinase gene expression is mediated through modulation of an already disrupted chromatin structure.

Authors:  Y T Ip; D K Granner; R Chalkley
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

9.  Periodicity of SNP distribution around transcription start sites.

Authors:  Koichiro Higasa; Kenshi Hayashi
Journal:  BMC Genomics       Date:  2006-04-03       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.